Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus low-carbohydrate versus balanced calorie-restricted diet in overweight or obese women with polycystic ovary syndrome
ChiCTR2100046320Phase 4Recruiting
- Sponsor
- Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoints: pregnancy rate and pregnancy outcome. Started Sep 2020; status: recruiting.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2100046320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046320.